Evidence map›Paper›PMID 14647193›Full record

ArticleGenes and immunity2003

FcgammaRIIB gene polymorphisms in Japanese periodontitis patients.

K Yasuda, N Sugita, T Kobayashi, K Yamamoto, H Yoshie

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 40 citations in OpenAlex.

  1. Lipopolysaccharide Impedes Bone Repair inInternational journal of molecular sciences · 2023
    Article
  2. Article
  3. Article
  4. Human FcR polymorphism and disease.Current topics in microbiology and immunology · 2014
    Review
  5. Review
  6. Gene polymorphisms in chronic periodontitis.International journal of dentistry · 2010
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K YasudaDivision of Periodontology, Department of Oral Biological Science, Niigata University, Graduate School of Medical and Dental Sciences, Gakkocho-Dori, Niigata, Japan.
N Sugita
T Kobayashi
K Yamamoto
H Yoshie
Niigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human type II low-affinity receptor for immunoglobulin G (FcgammaRII) constitutes a clustered gene family consisting of FcgammaRIIA, IIB and IIC genes. FcgammaRIIB is unique in its ability to transmit inhibitory signals in B cells via immunoreceptor tyrosine-based inhibitory motif (ITIM). B-cell activation and subsequent elevated production of IgG are the immunopathological features of inflammatory disease such as periodontitis. To determine whether an association with periodontitis susceptibility exists, genetic polymorphisms of FcgammaRIIB were examined in Japanese patients with aggressive periodontitis (AGP) and chronic periodontitis (CP), and in the race-matched healthy controls (HCs). A significant difference was observed in the distribution of FcgammaRIIB-232I/T allele (exon 5) between the AGP and HC groups, with enrichment of the 232T in the AGP group (P=0.006). In addition, the FcgammaRIIB-nt 646-184A/G allele (intron 4) distribution was significantly different between the CP and HC groups, with enrichment of the nt 646-184A in the CP group (P=0.011). These results document the association of FcgammaRIIB gene polymorphisms with susceptibility to periodontitis in the Japanese.

Indexed as

AllelesPhenotypePolymorphism, GeneticAdolescentAdultDNA PrimersFemaleGenotypeHaplotypesHumansJapanLinkage DisequilibriumMaleMiddle AgedPeriodontitisReceptors, IgGDNA PrimersFCGR2B protein, humanReceptors, IgG

Identifiers

PMID14647193
OpenAlexW1490645204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.